EVERZOM
Desconocido
INSPIRE: Developing novel inhaled bioengineered Extracellular Vesicle RNA based advanced therapeutics, delive...
EVERZOM
participó en un
HORIZON EUROPE:
HORIZON-HLTH-2021-TOOL-06
Lung cancer (LC) treatments have advanced in recent years with the advent of genetic profiling and immunotherapy. However, LC is a complex h...
2022-05-24 - 2025-05-31 | Financiado
2022-05-24 - 2025-05-31 | Financiado
ACROBAT: TowArd demoCRatization Of ev-BAsed Therapies
EVERZOM
tramitó un
HORIZON EUROPE:
HORIZON-EIC-2021-ACCELERATORCHALLENGES-01
EVerZom has developed a patented, fast, cost-effective, large-scale standardized extracellular vesicles (EV) production process to address t...
2022-04-28 - 2024-04-30 | Financiado
2022-04-28 - 2024-04-30 | Financiado
* No se disponen de datos de la empresa actual.